mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for BDH2
Gene summary
Basic gene Info.Gene symbolBDH2
Gene name3-hydroxybutyrate dehydrogenase, type 2
SynonymsDHRS6|EFA6R|PRO20933|SDR15C1|UCPA-OR|UNQ6308
CytomapUCSC genome browser: 4q24
Type of geneprotein-coding
RefGenesNM_020139.3,
Description3-hydroxybutyrate dehydrogenase type 2R-beta-hydroxybutyrate dehydrogenasedehydrogenase/reductase (SDR family) member 6dehydrogenase/reductase SDR family member 6oxidoreductase UCPAshort chain dehydrogenase/reductase family 15C, member 1
Modification date20141207
dbXrefs HGNC : HGNC
HPRD : 07103
ProteinUniProt: Q9BUT1
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_BDH2
BioGPS: 56898
PathwayNCI Pathway Interaction Database: BDH2
KEGG: BDH2
REACTOME: BDH2
Pathway Commons: BDH2
ContextiHOP: BDH2
ligand binding site mutation search in PubMed: BDH2
UCL Cancer Institute: BDH2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006635fatty acid beta-oxidation16380372
GO:0030855epithelial cell differentiation21492153


Top
Ligand binding site mutations for BDH2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
L57L57FBLCA1
R205K207NBLCA1
G178G178VLUAD1
S184S184YUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for BDH2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
L57L57F-1.4501082
R205K207N-1.1410526
G178G178V-0.52652771
S184S184Y-0.17127202
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for BDH2 from PDB

Top
Differential gene expression and gene-gene network for BDH2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of BDH2 and the right PPI network was created from samples without mutations in the LBS of BDH2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for BDH2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for BDH2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of BDH2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NADNAD ZWITTERION2ag5AL57 G178 S184
NADNAD ZWITTERION2ag5BL57 G178 S184
NADNAD ZWITTERION2ag5CL57 G178 S184
NADNAD ZWITTERION2ag5DL57 G178 S184
SO4SULFATE2ag5AR205
SO4SULFATE2ag5CR205
SO4SULFATE2ag5DR205


Top
Conservation information for LBS of BDH2
Multiple alignments for Q9BUT1 in multiple species
LBSAA sequence# speciesSpecies
A13VIVLTAAAQGI2Rattus norvegicus, Bos taurus
A13VIILTAAAQGI1Homo sapiens
A13VIVLSAAAQGI1Danio rerio
A82VLFNVAGFVHH3Homo sapiens, Rattus norvegicus, Bos taurus
A82VLFNIAGFVHH1Danio rerio
D37KVIATDINESK1Homo sapiens
D37QVTATDINGEK1Danio rerio
D37KVIATDINEAK1Rattus norvegicus
D37KVIATDINDSK1Bos taurus
D58QTRVLDVTKKK1Homo sapiens
D58KTKVVDVTKKD1Danio rerio
D58QTRVLDVTKKR1Rattus norvegicus
D58HTRVLDVTKKK1Bos taurus
F202EARNDFLKRQK1Homo sapiens
F202QAFKDFMARQR1Danio rerio
F202EALKAFLNRQK1Rattus norvegicus
F202EALSDFLKRQK1Bos taurus
G17TAAAQGIGQAA1Homo sapiens
G17SAAAQGIGKAS1Danio rerio
G17TAAAQGIGRAS1Rattus norvegicus
G17TAAAQGIGRAA1Bos taurus
G178NCVCPGTVDTP3Homo sapiens, Rattus norvegicus, Bos taurus
G178NCICPGTVDTP1Danio rerio
G83LFNVAGFVHHG3Homo sapiens, Rattus norvegicus, Bos taurus
G83LFNIAGFVHHG1Danio rerio
I18AAAQGIGQAAA1Homo sapiens
I18AAAQGIGKASA1Danio rerio
I18AAAQGIGRASA1Rattus norvegicus
I18AAAQGIGRAAA1Bos taurus
I38VIATDINESKL1Homo sapiens
I38VTATDINGEKL1Danio rerio
I38VIATDINEAKL1Rattus norvegicus
I38VIATDINDSKL1Bos taurus
K151VYSTTKAAVIG2Homo sapiens, Bos taurus
K151VYSTSKAAVIG1Danio rerio
K151VYSATKAAVIG1Rattus norvegicus
L104DFSMNLNVRSM3Homo sapiens, Rattus norvegicus, Bos taurus
L104DFTMNVNVRSM1Danio rerio
L185VDTPSLQERIQ3Homo sapiens, Rattus norvegicus, Bos taurus
L185VDTPSLRERIQ1Danio rerio
L57IQTRVLDVTKK2Homo sapiens, Rattus norvegicus
L57IKTKVVDVTKK1Danio rerio
L57IHTRVLDVTKK1Bos taurus
P177CNCVCPGTVDT3Homo sapiens, Rattus norvegicus, Bos taurus
P177CNCICPGTVDT1Danio rerio
P183GTVDTPSLQER3Homo sapiens, Rattus norvegicus, Bos taurus
P183GTVDTPSLRER1Danio rerio
Q16LTAAAQGIGRA2Rattus norvegicus, Bos taurus
Q16LTAAAQGIGQA1Homo sapiens
Q16LSAAAQGIGKA1Danio rerio
R144KGVVNRCVYST3Homo sapiens, Danio rerio, Bos taurus
R144KGVENRCVYSA1Rattus norvegicus
R188PSLQERIQARG1Homo sapiens
R188PSLRERIQARP1Danio rerio
R188PSLQERIQARD1Rattus norvegicus
R188PSLQERIQARP1Bos taurus
R205NDFLKRQKTGR1Homo sapiens
R205KDFMARQRTGR1Danio rerio
R205KAFLNRQKTGR1Rattus norvegicus
R205SDFLKRQKTGR1Bos taurus
S132NIINMSSVASS3Homo sapiens, Rattus norvegicus, Bos taurus
S132NIINMASVASS1Danio rerio
S184TVDTPSLQERI3Homo sapiens, Rattus norvegicus, Bos taurus
S184TVDTPSLRERI1Danio rerio
T182PGTVDTPSLQE3Homo sapiens, Rattus norvegicus, Bos taurus
T182PGTVDTPSLRE1Danio rerio
V180VCPGTVDTPSL3Homo sapiens, Rattus norvegicus, Bos taurus
V180ICPGTVDTPSL1Danio rerio
V59TRVLDVTKKKQ2Homo sapiens, Bos taurus
V59TKVVDVTKKDQ1Danio rerio
V59TRVLDVTKKRQ1Rattus norvegicus
V81DVLFNVAGFVH3Homo sapiens, Rattus norvegicus, Bos taurus
V81DVLFNIAGFVH1Danio rerio
V85NVAGFVHHGTI2Rattus norvegicus, Bos taurus
V85NVAGFVHHGTV1Homo sapiens
V85NIAGFVHHGSI1Danio rerio
Y147VNRCVYSTTKA2Homo sapiens, Bos taurus
Y147VNRCVYSTSKA1Danio rerio
Y147ENRCVYSATKA1Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas